Covered recipient · General Payments record
RAVALI REDDY KADARI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$332.98
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.98 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $111.35 | 1 |
| EISAI INC. | $59.79 | 2 |
| Acerta Pharma LLC | $48.10 | 3 |
| Nevro Corp. | $32.51 | 1 |
| PFIZER INC. | $23.17 | 1 |
| Exact Sciences Corporation | $21.17 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.45 | 1 |
| Amgen Inc. | $16.44 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $332.98 | 11 |
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.44 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117592636 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.99 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104629524 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.11 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104647737 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.00 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104728885 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.45 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117932569 | CMS |
| Eisai Inc. | $23.82 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110775445 | CMS |
| Eisai Inc. | $35.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110775447 | CMS |
| Exact Sciences Corporation | $21.17 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114724906 | CMS |
| Nevro Corp. | $32.51 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130754171 | CMS |
| Novo Nordisk Inc | $111.35 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097324811 | CMS |
| PFIZER INC. | $23.17 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131547394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.